This medication is a vaccine given to individuals over 2 years of age to prevent hepatitis A infection. It stimulates the body to produce antibodies against hepatitis A infection.
Severe immunodeficiency, allergic reaction (e.g., anaphylaxis) after a previous dose of any hepatitis A-containing vaccine, or to any component of Hepatitis A vaccine including neomycin.
Malignant disease being treated with chemotherapy or radiotherapy and for at least 6 months after stopping treatment.
Patients with compromised immune system such as those on high-dose systemic corticosteroids, immunosuppressant or HIV positive.
IM- Single dose of 0.5 or 1 ml depending on the product and patient's age. Give booster dose 6-12 months after the initial dose. Give via subcutaneous administration in haemophiliacs.
It comes as a solution for injection administered by a health care provider into the large muscle.
• Hepatitis A vaccine becomes effective after a period of at least 2 weeks. A second dose is administered 6 to 12 months after the first dose.
• It should not be used in children younger than 12 months old.
• Alcohol or disinfectant used for cleaning the skin prior to injection should be allowed to evaporate completely before vaccination to prevent vaccine inactivation.
• Caution needed for patients with history of illnesses or infections, blood disorders, immune system disorders, any allergies, pregnancy and breastfeeding.
• Central Nervous System:
Headache and tiredness.
• Local: Redness, soreness, swelling, redness, or warmth at the injection site and indurations at injection site.
• Miscellaneous: Loss of appetite, mild fever, nausea and transient soreness.
For IM injection only. Not for IV or intradermal administration.
It is usually handled and stored by a health care provider.
Subscribe to our Free Newsletters!